Related Experiment Video
Updated: Aug 6, 2026

Functional Imaging of Viral Transcription Factories Using 3D Fluorescence Microscopy
Published on: January 18, 2018
KSHV-K5 inhibits phosphorylation of the major histocompatibility complex class I cytoplasmic tail
1The R. W. Johnson Pharmaceutical Research Institute, 3210 Merryfield Row, San Diego, California 92121, USA.
Insights
Kaposi's sarcoma-associated herpesvirus (KSHV) proteins K3 and K5 internalize major histocompatibility complex class I (MHC I) molecules. This process does not require MHC I phosphorylation, indicating a distinct viral immune evasion mechanism.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Major histocompatibility complex class I (MHC I) molecules present antigens to T cells, crucial for immune surveillance.
- Kaposi's sarcoma-associated herpesvirus (KSHV) proteins K3 and K5 are known to downregulate MHC I.
- Intracellular trafficking of MHC I is influenced by its cytoplasmic tail, including phosphorylation sites.
Purpose of the Study:
- To investigate the role of MHC I phosphorylation in KSHV K3 and K5-mediated internalization.
- To elucidate the molecular mechanisms by which K3 and K5 downregulate MHC I.
- To compare the MHC I downregulation mechanisms of K3 and K5 with other viral proteins like HIV nef.
Main Methods:
- Utilized in vivo labeling experiments to assess MHC I phosphorylation.
- Employed deletion and mutation studies of the MHC I tail.
- Analyzed the effect of KSHV K3 and K5 proteins, including mutated K5 variants, on MHC I expression and trafficking.
Main Results:
- KSHV K3 and K5 proteins mediate the internalization of MHC I molecules.
- MHC I phosphorylation was found to be inhibited in K5-transfected cells, but this inhibition did not cause internalization.
- Both K3 and K5 could downregulate MHC I even when conserved phosphorylation sites were absent, suggesting phosphorylation is not the cause.
- Minimal MHC I tail sequences required for downregulation differed between K3, K5, and HIV nef.
Conclusions:
- KSHV K3 and K5 downregulate MHC I through a mechanism distinct from other viral immune evasion strategies.
- Inhibition of MHC I phosphorylation by K5 is a consequence, not a cause, of MHC I internalization.
- The carboxy-terminal region of MHC I is essential for K3 and K5-mediated internalization, but the specific requirements vary between these viral proteins.
Abstract:
The carboxy-terminal region of major histocompatibility complex class I (MHC I) molecules is required for the rapid internalization mediated by Kaposi's sarcoma-associated herpesvirus (KSHV) proteins K3 and K5. The cytoplasmic tail of MHC I contains highly conserved serine phosphorylation sites that have been implicated in intracellular trafficking. Indeed, in vivo labeling experiments reveal a lack of MHC I phosphorylation in K5-transfected HeLa cells. Phosphorylation of the MHC I tail was restored upon mutation of the PHD/LAP domain of K5. However, deletion and mutation studies of the MHC I tail show that both K3 and K5 are able to downregulate MHC I lacking the conserved phosphorylation site. This result suggests that inhibition of phosphorylation reflects, but does not cause, MHC I internalization. Interestingly, K3 and K5 differ from each other, as well as from human immunodeficiency virus nef, with respect to the minimal MHC I tail sequences required for MHC downregulation. These data support the notion that K3 and K5 downregulate MHC I molecules by a distinct molecular mechanism that is different from other viral immune evasion molecules.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Anaphase Promoting Complex
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway

